Aventis Confirms Supervisory Board Rejects Bid
French drugmaker Aventis (AVEP.PA: Quote, Profile, Research) confirmed on Wednesday it had unanimously rejected an unsolicited takeover bid by smaller rival Sanofi-Synthelabo (SASY.PA: Quote, Profile, Research) .